Codon 215 mutations in human immunodeficiency virus-infected pregnant women

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 705-708

  Kully, Charlotte ^a,b,c   Yerly, Sabine ^a,b,c   Erb, Peter ^a,b,c   Kind, Christian ^a,b,c   Krautheim, Alexandra ^a,b,c   Perrin, Luc ^a,b,c   Rudin, Christoph ^a,b,c   Biedermann, K ^a,b,c   Irion, O ^a,b,c   Lauper, U ^a,b,c   Poorbeik, M ^a,b,c   Joller, H I ^a,b,c   Schreyer, A ^a,b,c   Spoletini, G ^a,b,c   Vernazza, P ^a,b,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LAMIVUDINE; ZIDOVUDINE;

ARTICLE; CODON; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MUTATION RATE; PREGNANCY; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS MUTATION; VIRUS TRANSMISSION;

AMINO ACID SUBSTITUTION; ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SWITZERLAND; ZIDOVUDINE;

EID: 0033386254     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314615     Document Type: Article

References (15)

1. 1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. 2. Cooper ER, Nugent RP, Diaz C, et al. After AIDS Clinical Trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996;174:1207-11.
3. 3. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus from mother to infant. N Engl J Med 1996;335:1621-9.
4. 4. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47(RR-2):1-30.
5. 5. Recommendations of the U.S. Public Health Service Task Force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43(RR-11):1-20.
6. 6. Larder BA, Kemp SD. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989;246: 1155-8.
7. 7. Siegrist CA, Yerly S, Kaiser L, Wyler CA, Perrin L. Mother to child transmission of zidovudine-resistant HIV-1. Lancet 1994;344:1771-2.
8. 8. Weisser M, Rudin C, Battegay M, et al. Does pregnancy influence the course of HIV infection? Evidence from two large Swiss Cohort studies. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:404-10.
9. 9. Kind C, Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission: additive protective effect of elective caesarean section and zidovudine prophylaxis. AIDS 1998;12:205-10.
10. 10. Chomczynski P, Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
11. 11. Larder BA, Kellam P, Kemp SD. Zidovudine resistance predicted by direct detection of mutation in DNA from HIV-infected lymphocytes. AIDS 1991;5:137-44.
12. 12. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989;243: 1731-4.
13. 13. Ericc A, Mayers DL, Strike DG, et al. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 1993;328:1163-5.
14. 14. Eastman P, Shapíro D, Coombs R, et al. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis 1998;177:557-64.
15. 15. Lorenzi P, Masserey-Spicher V, Laubereau B, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1999 (in press).